(Q44371883)

2 December 2017

Lack of c-kit exon 11 activating mutations in c-KIT/CD117-positive SCLC tumour specimens (English)

1 reference

lung small cell carcinoma

2 December 2017

1 reference

Burger H

1

1 reference

2 December 2017

den Bakker MA

2

1 reference

2 December 2017

Stoter G

3

1 reference

2 December 2017

Verweij J

4

1 reference

2 December 2017

Nooter K

5

1 reference

2 December 2017

1 April 2003

1 reference

European Journal of Cancer

2 December 2017

1 reference

2 December 2017

39

1 reference

2 December 2017

793-799

1 reference

2 December 2017

6

1 reference

Class III receptor tyrosine kinases: role in leukaemogenesis

2 December 2017

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2803%2900026-1

7 January 2021

Tyrosine kinase oncogenes in normal hematopoiesis and hematological disease

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2803%2900026-1

7 January 2021

Inhibition of KIT tyrosine kinase activity: a novel molecular approach to the treatment of KIT-positive malignancies

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2803%2900026-1

7 January 2021

Classes of c-KIT activating mutations: proposed mechanisms of action and implications for disease classification and therapy

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2803%2900026-1

7 January 2021

Gastrointestinal stromal tumors--definition, clinical, histological, immunohistochemical, and molecular genetic features and differential diagnosis

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2803%2900026-1

7 January 2021

Clinical management of gastrointestinal stromal tumors: before and after STI-571.

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2803%2900026-1

7 January 2021

Mutations in exon 11 of c-Kit occur preferentially in malignant versus benign gastrointestinal stromal tumors and do not occur in leiomyomas or leiomyosarcomas

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2803%2900026-1

7 January 2021

Mutations in exons 9 and 13 of KIT gene are rare events in gastrointestinal stromal tumors. A study of 200 cases

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2803%2900026-1

7 January 2021

Activity of a specific inhibitor of the BCR-ABL tyrosine kinase in the blast crisis of chronic myeloid leukemia and acute lymphoblastic leukemia with the Philadelphia chromosome

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2803%2900026-1

7 January 2021

Chronic myeloid leukemia: current treatment options

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2803%2900026-1

7 January 2021

Safety and efficacy of imatinib (STI571) in metastatic gastrointestinal stromal tumours: a phase I study

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2803%2900026-1

7 January 2021

STI571: a magic bullet?

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2803%2900026-1

7 January 2021

Twenty years of phase III trials for patients with extensive-stage small-cell lung cancer: perceptible progress

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2803%2900026-1

7 January 2021

State of the art in systemic treatment of lung cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2803%2900026-1

7 January 2021

KIT expression in angiosarcomas and fetal endothelial cells: lack of mutations of exon 11 and exon 17 of C-kit

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2803%2900026-1

7 January 2021

Growth inhibition and modulation of kinase pathways of small cell lung cancer cell lines by the novel tyrosine kinase inhibitor STI 571

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2803%2900026-1

7 January 2021

Efficacy and safety of imatinib mesylate in advanced gastrointestinal stromal tumors

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2803%2900026-1

7 January 2021

10.1016/S0959-8049(03)00026-1

Identifiers

DOI

1 reference

2 December 2017

1 reference